Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: John M. McCann who wrote (2163)	8/27/2001 9:09:07 PM
From: Marshall Teitelbaum	Read Replies (1) \| Respond to of 2205

Hey Jack. Long time, no speak. Hope all is well your way. Lots of rumors, hard/impossible to confirm any of them. Interesting announcement today about upcoming ATIS events, especially two of them, both involving "Cardiac Function Following Acute Infarction: Effect of Human Fibroblast Epicardial Patch", by Robert Kellar, PhD, one on 9/10 and one on 11/11, at the Heart Failure Society in Wash., D.C. and at the American Heart Association Scientific Session in Anaheim, CA, respectively. Sounds like there is some type of new data regarding the use of this patch following acute myocardial infarction, although it is difficult to see for sure in what species or what number of subjects, etc. Regardless, scheduled presentations aren't made to discuss poor findings or lack of efficacy in this type of situation, so I expect that this is at least partially associated with the recent price changes. Depending on what is shared on 9/10, there could be more action. My best to the rest of the gang here. I apologize for only coming around sparingly, but there is little free time. Hope you're still enjoying your market research, Bruce! Regards, Marshall